---
reference_id: "PMID:33626435"
title: "Seizures in systemic lupus erythematosus: A scoping review."
authors:
- Rodriguez-Hernandez A
- Ortiz-Orendain J
- Alvarez-Palazuelos LE
- Gonzalez-Lopez L
- Gamez-Nava JI
- Zavala-Cerna MG
journal: Seizure
year: '2021'
doi: 10.1016/j.seizure.2021.02.021
content_type: abstract_only
---

# Seizures in systemic lupus erythematosus: A scoping review.
**Authors:** Rodriguez-Hernandez A, Ortiz-Orendain J, Alvarez-Palazuelos LE, Gonzalez-Lopez L, Gamez-Nava JI, Zavala-Cerna MG
**Journal:** Seizure (2021)
**DOI:** [10.1016/j.seizure.2021.02.021](https://doi.org/10.1016/j.seizure.2021.02.021)

## Content

1. Seizure. 2021 Mar;86:161-167. doi: 10.1016/j.seizure.2021.02.021. Epub 2021
Feb  17.

Seizures in systemic lupus erythematosus: A scoping review.

Rodriguez-Hernandez A(1), Ortiz-Orendain J(2), Alvarez-Palazuelos LE(3), 
Gonzalez-Lopez L(4), Gamez-Nava JI(5), Zavala-Cerna MG(6).

Author information:
(1)Facultad de Medicina, Universidad Autónoma de Guadalajara, Guadalajara, 
Jalisco, Mexico. Electronic address: adrian_rodriguezh@hotmail.com.
(2)Department of Psychiatry, Mayo Clinic- Rochester, Rochester, MN, United 
States. Electronic address: jaortzor@gmail.com.
(3)Facultad de Medicina, Universidad Autónoma de Guadalajara, Guadalajara, 
Jalisco, Mexico; Doctorado en Ciencias Biomédicas Neurociencias, Universidad de 
Guadalajara, Mexico. Electronic address: lucia.palazuelos@edu.uag.mx.
(4)Programa de Doctorado en Salud Publica y Doctorado en Farmacologia, Centro 
Universitario de Ciencias de la Salud universidad de Guadalajara, 44340 
Guadalajara, JAL, Mexico. Electronic address: dralauragonzalez@prodigy.net.mx.
(5)Programa de Doctorado en Salud Publica y Doctorado en Farmacologia, Centro 
Universitario de Ciencias de la Salud universidad de Guadalajara, 44340 
Guadalajara, JAL, Mexico. Electronic address: drivangamez@prodigy.net.mx.
(6)Immunology Research Laboratory, International Program of Medicine, 
Universidad Autonoma de Guadalajara, Zapopan, JAL, Mexico. Electronic address: 
maria.cerna@edu.uag.mx.

Systemic lupus erythematosus is a systemic autoimmune disease that affects the 
central nervous system, either by direct neuronal damage, injury to brain 
vessels, or by pathogenic mechanisms indirectly induced by immune mechanisms 
related to the production and deposition of immune complexes. The prevalence of 
explicit episodes of seizures among SLE patients, varies from 2 to 8%. In some 
cases, patients with positivity for antiphospholipid or anti-β2 glycoprotein 
antibodies are found to be more prone to exhibit seizures compared to 
seronegative patients, other subjects at risk are carries of gene abnormalities 
codifying for ion channels. The exclusion of vasculitis or thrombosis is 
required for accurate treatment, imaging studies and alternative sequences are 
mandatory in patients with known SLE who present with a seizure. Several 
statements regarding SLE-related seizure remain to be decoded. In this scoping 
review we analyzed published information about prevalence, pathogenesis, 
clinical characteristics, diagnostic and therapeutic SLE patients that manifest 
a seizure, our objective is to provide with useful information for prompt 
diagnosis and individualized treatment.

Copyright © 2021 British Epilepsy Association. Published by Elsevier Ltd. All 
rights reserved.

DOI: 10.1016/j.seizure.2021.02.021
PMID: 33626435 [Indexed for MEDLINE]